USPTO serial 79357589
AQUMELDI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 21, 2024
- Examiner
- GAYNOR, BARBARA ANNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AQUMELDI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in manufacturing pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of drugs for treating hypertension in children from birth through age 17; reagents for medical research; diagnostic reagents for scientific use | ACTIVE | — |
| 005 | Medicines for human purposes for the treatment of hypertension in children from birth through age 17; drugs for the treatment of hypertension in children from birth through age 17; chemical preparations for pharmaceutical purposes, namely, for the treatment of hypertension in children from birth through age 17; chemical preparations for medical purposes, namely, for the treatment of hypertension in children from birth through age 17; chemical reagents for medical purposes; diagnostic agents, preparations and substances for medical purposes; reactants for medical diagnosis, namely, diagnostic preparations for medical purposes | ACTIVE | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; research and development of vaccines and medicines; research relating to medicines; pharmaceutical product evaluation, namely, assessing the efficiency of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of chemicals | ACTIVE | — |
| 044 | Medical treatment of hypertension in children from birth through age 17; provision of medical assistance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Proveca Limited
- Other trademarks owned by Proveca Limited
- Other trademarks owned by Proveca Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AQUMELDI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 21, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 21, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 15, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 5, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 14, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 14, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 26, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 24, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 15, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 1, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 1, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 15, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 14, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |